The strong Bionaturis (BNT. MC) commitment of consolidating its international growth strategy, presence and professionalization in the financial markets has become real with the appointment of Juan Juarez as a Board Member since last June, 30. As part of the operation, Juarez has acquired 5% of the biotech.

Juan Juarez, degree in Laws at Madrid University and in Economics at Madrid-ICADE, Master in Finance from the IE (Madrid) and Master in Financial Markets (Madrid Stock Exchange), besides of being part of management teams in banks and financial entities, is nowadays an executive and founding partner of companies as Privat und Handel Bank Zürich AG, Ad-Hoc Aesores EAFI SA and Juarez & Asociados –Family Office SA. Juarez is also member of the Board of Directors and financial vice-president at Carbures Group and he is considered a key person in the outstanding growth of the company of composite structures, that has already announced its goal of start quoting soon in the continuous market.

The strategic movement is completed with the increase of shareholding position by Rafael Contreras, member of the Boards of Directors of the biotech company since 2011. Rafael Contreras, in a direct and indirect way, increases his ownership up to 7,5%. Contreras is CEO at Carbures Group and is leading its outperforming international expansion.

As it has been published as Relevant Fact, Victor Infante, CEO and Bionaturis main shareholder, has reduced its participation until 43,06%, as a result of the abovementioned movement. About the operation, Victor Infante has stated: “Bionaturis gains unbeatable conditions to fulfill our growth plan. Their track record in Carbures Group has been impressive”.

The exchanged shares shall keep the original lock-up, held to CEO´s shares.


About Carbures

Carbures is an industrial technological group specialized in manufacturing composites structures, such as carbon fiber, for the industries related to mobility as aerospace, self-propulsion, railway, sportive and civil construction. During 15 years of intense R&D, Carbures has developed a proprietary technology that has situated the company as the leader in Europe in carbon fiber assembly lines to produce serial pieces for planes, cars, trains, bikes, structures and construction girders.


About Bionaturis

The biotechnological company  pursuing a vision of a global access to health, ended up last year with a sales increase of 96% and a positive EBITDA of €+ 967 thousand regarding 2012 exercise. The estimations for 2014 forecasts an increase around 400% in revenues, supported by an ambitious international expansion plan in Asia and LATAM.